Literature DB >> 20880185

Alterations of muscarinic acetylcholine receptors-2, 4 and α7-nicotinic acetylcholine receptor expression after ischaemia / reperfusion in the rat isolated heart.

Dong-Ling Li1, Bing-Hang Liu, Lei Sun, Mei Zhao, Xi He, Xiao-Jiang Yu, Wei-Jin Zang.   

Abstract

1. Cardiac acetylcholine receptors are involved in the negative inotropic effect of the vagus and the protection of the stimulated vagal nerve against myocardial ischaemic injury. Acetylcholine receptors consist of five types of muscarinic acetylcholine receptors (M AChR) and several nicotinic acetylcholine receptors (nAChR). Notably, ischaemic heart disease is accompanied by substantial withdrawal of vagal activity. However, it is not entirely clear what the changes of M(2,4) AChR and α7-nAChR expression are after cardiac ischaemia/reperfusion (I/R) injury. 2. Cardiac functions were continuously recorded in Langendorff mode during 30 min of ischaemia and 60 min of reperfusion. Lactate dehydrogenase (LDH) leakage was measured. M(2,4) AChRs and α7-nAChR expression were measured by reverse transcription polymerase chain reaction and western blot. 3. In hearts exposed to I/R injury, left ventricular development pressure, heart rate and ± dP/dt decreased significantly compared with the controls. LDH leakage increased with respect to the controls during reperfusion. 4. In normal hearts, expression of M(2,4) AChR in the left ventricle were lower than in atria and the right ventricle, whereas expression of α7-nAChR was dramatically higher in the left ventricle and right ventricle than the atria. After reperfusion, the mRNA and protein expression of M(2) AChR increased notably in the left and right ventricle, and α7-nAChR was enhanced significantly in the left ventricle. M(4) AChR mRNA expression reduced notably after ischaemia and recovered to the control level after reperfusion in the atria, but the protein level did not change. 5. In conclusion, the increase in M(2) AChR and α7-nAChR after reperfusion might be the compensatory response to myocardial I/R injury, providing new information for treatment of myocardial I/R injury.
© 2010 The Authors. Clinical and Experimental Pharmacology and Physiology © 2010 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880185     DOI: 10.1111/j.1440-1681.2010.05448.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

Review 1.  Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases.

Authors:  Chong Liu; Dingfeng Su
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

2.  Cholinergic receptors play a role in the cardioprotective effects of anesthetic preconditioning: Roles of nitric oxide and the CaMKKβ/AMPK pathway.

Authors:  Yang Yang; Ying Li; Jie Wang; Lei Hong; Shigang Qiao; Chen Wang; Jianzhong An
Journal:  Exp Ther Med       Date:  2020-12-14       Impact factor: 2.447

3.  Aqueous extracts of Liriope platyphylla induced significant laxative effects on loperamide-induced constipation of SD rats.

Authors:  Ji Eun Kim; Young Ju Lee; Moon Hwa Kwak; Jun Ko; Jin Tae Hong; Dae Youn Hwang
Journal:  BMC Complement Altern Med       Date:  2013-11-26       Impact factor: 3.659

Review 4.  Autonomic nervous system involvement in pulmonary arterial hypertension.

Authors:  Mylène Vaillancourt; Pamela Chia; Shervin Sarji; Jason Nguyen; Nir Hoftman; Gregoire Ruffenach; Mansoureh Eghbali; Aman Mahajan; Soban Umar
Journal:  Respir Res       Date:  2017-12-04

Review 5.  Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.

Authors:  Kannaporn Intachai; Siriporn C Chattipakorn; Nipon Chattipakorn; Krekwit Shinlapawittayatorn
Journal:  Int J Mol Sci       Date:  2018-08-21       Impact factor: 5.923

6.  Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation.

Authors:  Ping Li; Yaoyao Yan; Youyang Shi; Bo Cheng; Yi Zhan; Qiaoyu Wang; Qiaofang Ye; Yawen Weng; Tingting Wu; Rongzhou Wu
Journal:  Oxid Med Cell Longev       Date:  2019-03-07       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.